CVR: 34896828
AVILEX PHARMA ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Kristian Strømgaard. The company's owners include Novo Holdings A/S, MIKAEL SØNDERGÅRD THOMSEN ApS and KRISTIAN STRØMGAARD HOLDING ApS. The company has 3 employees. In 2024, the company reported a net result of DKK -4,428,000 compared with DKK -6,756,000 the year before. Equity amounted to DKK -6,267,000.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er udvikling af behandlingsmæssige peptider eller afledte peptider (monomer, dimer og trimer) eller små molekylære forbindelser som er rettet mod PDZ domæner og relateret virksomhed besluttet af bestyrelsen.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | - | -4.4 mio. | 21.6 mio. | -6.3 mio. | 2 | |
| 2023 | 0 | -6.8 mio. | 27.9 mio. | -1.8 mio. | 2 | |
| 2022 | 45.5 mio. | 28.6 mio. | 31.6 mio. | 4.9 mio. | 2 | |
| 2021 | - | -6.6 mio. | 4.9 mio. | -25.3 mio. | 2 | |
| 2020 | - | -3 mio. | 9.4 mio. | -18.6 mio. | 2 | |
| 2019 | - | -3.7 mio. | 9.4 mio. | -15.6 mio. | 4 | |
| 2018 | - | -3.9 mio. | 6.7 mio. | -11.9 mio. | 1 | |
| 2017 | - | -2.4 mio. | 7.3 mio. | -8.1 mio. | 1 | |
| 2016 | - | -5.5 mio. | 4.8 mio. | -5.7 mio. | 1 | |
| 2015 | - | -7.6 mio. | 10.4 mio. | -279 t. | 3 | |
| 2014 | - | -1.2 mio. | 1.3 mio. | -4.1 mio. | 0 | |
| 2013 | - | -2.9 mio. | 2.2 mio. | -2.9 mio. | - |
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorCompared to 1.052 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
AVILEX PHARMA ApS has published its annual report for 2024. The net result was DKK -4,428,000.
As of June 6, 2025, Camilla Petrycer Hansen has joined the board of directors of AVILEX PHARMA ApS.
As of June 6, 2025, Morten Døssing has left the board of directors of AVILEX PHARMA ApS.
AVILEX PHARMA ApS has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK -6,756,000.
AVILEX PHARMA ApS has published its annual report for 2022. Revenue came to DKK 45,479,000, and the net result was DKK 28,600,000.
As of September 23, 2022, Novo Holdings A/S is registered as an owner of AVILEX PHARMA ApS with an ownership share of 50%.
As of August 31, 2022, EY Godkendt Revisionspartnerselskab has been appointed auditor of AVILEX PHARMA ApS.
As of August 31, 2022, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of AVILEX PHARMA ApS.
AVILEX PHARMA ApS has published its annual report for 2021. The net result was DKK -6,611,177.
AVILEX PHARMA ApS has published its annual report for 2020. Gross profit came to DKK -3,132,649, and the net result was DKK -3,041,705.
As of December 31, 2020, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of AVILEX PHARMA ApS.
As of December 31, 2020, Grant Thornton, Godkendt Revisionspartnerselskab has stepped down as auditor of AVILEX PHARMA ApS.
AVILEX PHARMA ApS has published its annual report for 2019. The net result was DKK -3,726,433.
AVILEX PHARMA ApS has published its annual report for 2018. The net result was DKK -3,860,576.
As of January 11, 2019, MIKAEL SØNDERGÅRD THOMSEN ApS is registered as an owner of AVILEX PHARMA ApS with an ownership share of 5%.
As of January 11, 2019, KRISTIAN STRØMGAARD HOLDING ApS is registered as an owner of AVILEX PHARMA ApS with an ownership share of 20%.
As of January 11, 2019, Anders Bach ApS is registered as an owner of AVILEX PHARMA ApS with an ownership share of 10%.
As of December 21, 2018, Morten Døssing has joined the board of directors of AVILEX PHARMA ApS.
As of December 21, 2018, Emmanuelle Coutanceau has left the board of directors of AVILEX PHARMA ApS.
AVILEX PHARMA ApS has published its annual report for 2017. The net result was DKK -2,415,685.
As of May 1, 2018, Jonathan Mark Treherne has joined the board of directors of AVILEX PHARMA ApS.
As of May 1, 2018, Jonathan Mark Treherne has stepped down as adm. dir. of AVILEX PHARMA ApS.
AVILEX PHARMA ApS has published its annual report for 2016. The net result was DKK -5,450,675.
As of May 20, 2016, Raymond George Hill has joined the board of directors of AVILEX PHARMA ApS.
As of May 20, 2016, Emmanuelle Coutanceau has joined the board of directors of AVILEX PHARMA ApS.
AVILEX PHARMA ApS has published its annual report for 2015. The net result was DKK -7,570,524.
As of May 19, 2016, Raymond George Hill has left the board of directors of AVILEX PHARMA ApS.
As of May 19, 2016, Emmanuelle Coutanceau has left the board of directors of AVILEX PHARMA ApS.
As of January 17, 2016, Kristian Strømgaard is registered as director of AVILEX PHARMA ApS.
As of January 17, 2016, Jonathan Mark Treherne is registered as adm. dir. of AVILEX PHARMA ApS.
As of January 16, 2016, Kristian Strømgaard has stepped down as adm. dir. of AVILEX PHARMA ApS.
As of September 1, 2015, Emmanuelle Coutanceau has joined the board of directors of AVILEX PHARMA ApS.
As of August 14, 2015, Bobby G Soni has left the board of directors of AVILEX PHARMA ApS.
AVILEX PHARMA ApS has published its annual report for 2014. The net result was DKK -1,224,080.
As of March 2, 2015, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of AVILEX PHARMA ApS.
As of March 2, 2015, EY Godkendt Revisionspartnerselskab has stepped down as auditor of AVILEX PHARMA ApS.
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of AVILEX PHARMA ApS.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of AVILEX PHARMA ApS.
As of September 2, 2014, Bobby G Soni has joined the board of directors of AVILEX PHARMA ApS.
As of September 2, 2014, Henrijette Elsebeth Richter has left the board of directors of AVILEX PHARMA ApS.
AVILEX PHARMA ApS has published its annual report for 2013. The net result was DKK -2,948,947.
As of January 2, 2014, Henrijette Elsebeth Richter has joined the board of directors of AVILEX PHARMA ApS.
As of January 2, 2014, Ingelise Saunders has left the board of directors of AVILEX PHARMA ApS.
As of December 31, 2013, Kristian Strømgaard is registered as adm. dir. of AVILEX PHARMA ApS.
As of December 31, 2013, Nanna Liebach Lüneborg has stepped down as director of AVILEX PHARMA ApS.
As of July 1, 2013, Nanna Liebach Lüneborg is registered as director of AVILEX PHARMA ApS.
As of July 1, 2013, Robert Giles Tansley has stepped down as adm. dir. of AVILEX PHARMA ApS.
As of February 21, 2013, JUT NR. 2180 A/S has been appointed auditor of AVILEX PHARMA ApS.
As of February 21, 2013, EY Danmark A/S has stepped down as auditor of AVILEX PHARMA ApS.
As of February 18, 2013, Ingelise Saunders has joined the board of directors of AVILEX PHARMA ApS.
As of February 18, 2013, Raymond George Hill has joined the board of directors of AVILEX PHARMA ApS.
As of February 18, 2013, Anders Bach has left the board of directors of AVILEX PHARMA ApS.
As of February 18, 2013, Robert Giles Tansley is registered as adm. dir. of AVILEX PHARMA ApS.
As of December 27, 2012, EY Danmark A/S has been appointed auditor of AVILEX PHARMA ApS.
As of December 27, 2012, Kristian Strømgaard has joined the board of directors of AVILEX PHARMA ApS.
As of December 27, 2012, Anders Bach has joined the board of directors of AVILEX PHARMA ApS.
AVILEX PHARMA ApS was founded on December 27, 2012.
Companies in the same industry and area
CVR 45436497
CVR 46543912
CVR 40766383
CVR 42731323
CVR 38599119
companydata.dk